Compounds > naltrexone

naltrexone and Nervous System Diseases

naltrexone has been researched along with Nervous System Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, C; Jeong, H; Jeong, S; Kim, SJ; Lee, J; Lee, S; Yoo, KY1
Brune, A; Luger, TA; Metze, D; Ständer, S1
Meyers, CA; Talpaz, M; Valentine, AD1
Coudoré-Civiale, MA; Courteix, C; Eschalier, A; Fialip, J; Privat, AM; Zajac, JM1
Williams, A1

Trials

2 trial(s) available for naltrexone and Nervous System Diseases

ArticleYear
[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:12

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Pruritus; Tachyphylaxis; Treatment Outcome

2004
Treatment of neurotoxic side effects of interferon-alpha with naltrexone.
    Cancer investigation, 1995, Volume: 13, Issue:6

    Topics: Adult; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Naltrexone; Nervous System Diseases; Thrombocythemia, Essential

1995

Other Studies

4 other study(ies) available for naltrexone and Nervous System Diseases

ArticleYear
Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats.
    Journal of neurosurgical anesthesiology, 2012, Volume: 24, Issue:1

    Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Carbon Dioxide; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Interleukin-6; Ischemic Attack, Transient; Male; Mitogen-Activated Protein Kinases; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Neuroprotective Agents; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Reperfusion Injury; Tumor Necrosis Factor-alpha

2012
[Antipuritic therapy with naltrexone].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2005, Volume: 56, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Pruritus; Tachyphylaxis; Treatment Outcome

2005
Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
    British journal of pharmacology, 1999, Volume: 127, Issue:6

    Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperalgesia; Injections, Spinal; Male; Morphine; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Oligopeptides; Pain; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors; Vocalization, Animal

1999
Primary care of parenteral substance abusers.
    The Nurse practitioner, 1986, Volume: 11, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Cocaine; Female; Heart Diseases; Hepatitis; Heroin Dependence; HIV Antibodies; Humans; Injections, Intradermal; Injections, Intravenous; Kidney Diseases; Male; Menstruation Disturbances; Methadone; Naltrexone; Nervous System Diseases; Primary Health Care; Respiratory Tract Diseases; Substance-Related Disorders

1986